News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Is AstraZeneca PLC (AZN) Eyeing Forest Laboratories, Inc. (FRX)?


3/22/2012 9:48:03 AM

AstraZeneca could be on the acquisition trail, analysts believe, with US group Forest Laboratories tipped as a prime target. Liberum Capital moved its recommendation on Astra from sell to buy, based partly on the belief that the chances of the company doing a deal have increased. It pointed to a number of factors: a poor drug pipeline and the need to buy earnings, impending patent expiries from 2014, a new chairman with an acquisition background joining in September (ex-Volvo and Ericsson executive Leif Johansson) and the company returning to a net cash position in the last 18 months.

Read at Guardian

comments powered by Disqus
Guardian
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES